Microdosing GLP-1s: What the Clinical Evidence Actually Shows
Microdosing semaglutide and tirzepatide is an off-label trend with mixed evidence. The biology is plausible, but the clinical validation for microdoses specifically is thinner than the marketing suggests. Here is what the data actually shows.




